• No results found

Erin L. St. Onge

N/A
N/A
Protected

Academic year: 2021

Share "Erin L. St. Onge"

Copied!
14
0
0

Loading.... (view fulltext now)

Full text

(1)

Home: Office:

2732 Cabernet Circle University of Florida

Ocoee, FL 34761 Research and Academic Center at Lake Nona

Phone: (407)721-7560 College of Pharmacy

Email: [email protected] 6550 Sanger Rd

Orlando, FL 32827 Phone: (407)313-7004 EDUCATION/TRAINING

July 1999 to June 2000 Community Clinical Pharmacy Residency Saint Louis College of Pharmacy

Walgreens

Saint Louis, Missouri

August 1995 to June 1999 Doctor of Pharmacy

University of Florida College of Pharmacy Gainesville, Florida

Graduated with High Honors

August 1992 to May 1995 Undergraduate Studies

University of Central Florida, Orlando, Florida University of Florida, Gainesville, Florida University of South Florida, Tampa, Florida

August 1990 to May 1992 Associate in Arts

Valencia Community College Orlando, Florida

OTHER TRAINING

August 2009 to July 2010 Academic Leadership Fellows Program American Association of Colleges of Pharmacy

ACADEMIC APPOINTMENTS

June 2012 to present Assistant Dean for the Orlando Campus Campus Director/Clinical Associate Professor University of Florida College of Pharmacy Gainesville, Florida

(2)

July 2002 to June 2012 Assistant Dean for the Orlando Campus Campus Director/Clinical Assistant Professor University of Florida College of Pharmacy Gainesville, Florida

July 2000 to May 2002 Assistant Professor, Pharmacy Practice Texas Tech HSC School of Pharmacy Lubbock, Texas

July 1999 to June 2000 Clinical Instructor, Pharmacy Practice Saint Louis College of Pharmacy

Saint Louis, Missouri

PROFESSIONAL EXPERIENCE

July 2002 to present Assistant Dean/Campus Director

University of Florida College of Pharmacy – Orlando Campus Orlando, Florida

Responsibilities include continuing development of the campus, overseeing all campus activities, creating campus schedules, planning and implementing courses, facilitating classes, advising students in coursework and organizational activities, developing campus programs and activities, serving as a liaison between professors in Gainesville and Orlando, managing the campus budget, hiring exam proctors and course facilitators, recruiting preceptors and faculty advisors, and developing new research.

July 2010 to present Orange Blossom Family Health Center Orlando, Florida

Clinical responsibilities include monitoring and managing warfarin therapy in patients referred by physicians/PAs/ARNPs, educating and managing patients with diabetes referred by

physicians/PAs/ARNPs, providing pharmacotherapy consults on selected patients, serving as a drug information resource for other health care professionals within the practice, and precepting 4th year pharmacy students on clerkships.

March 2008 to present Florida Hospital Family Practice Residency Orlando, Florida

Clinical responsibilities include monitoring and managing warfarin therapy in patients referred by internal physicians/medical residents, serving as a drug information resource for other health care

professionals within the practice, and assisting in precepting 4th year pharmacy students on clerkships.

(3)

October 2007 to December 2007 Orange County Medical Clinic Orlando, Florida

Clinical responsibilities include monitoring and managing warfarin therapy in patients referred by internal and external physicians.

Assist in precepting 4th year pharmacy students on clerkships.

June 2005 to December 2006 Veterans Affairs Outpatient Clinic Winter Park, Florida

Clinical responsibilities include assessing control of diabetes, hypertension, and hyperlipidemia, monitoring and recommending changes in therapy as needed, assisting in non-formulary request approvals/denials, and precepting 4th year pharmacy students on clerkships.

July 2000 to May 2002 Clinical Pharmacist

United Supermarkets Pharmacy Lubbock, Texas

Clinical practice responsibilities included developing disease state management programs (hypertension, diabetes, smoking cessation, hyperlipidemia), patient education and counseling, drug information requests, and precepting clerkship students. Specialty certifications include smoking cessation, immunization delivery, and diabetes.

October 2001 to May 2002 Veterans Affairs Outpatient Clinic Lubbock, Texas

Clinical practice responsibilities included teaching medication portion of diabetes education class, assessing control of diabetes, hypertension, and hyperlipidemia, monitoring/changing therapy as needed, and precepting students on P3 and P4 clerkships.

July 1999 to June 2000 Community Clinical Pharmacy Residency Saint Louis College of Pharmacy

Walgreens

Saint Louis, Missouri

Clinical practice responsibilities included developing or maintaining disease state management programs (hypertension, diabetes,

smoking cessation, hypercholesterolemia, asthma, gastroesophageal reflux disease), patient education and counseling, development of educational newsletter for pharmacists, and precepting clerkship students. Elective rotations included managed care, family medicine, and ambulatory care.

(4)

August 1989 to June 2000 Walgreens

Several locations in Florida and Missouri, Supervisors: Erica Schroeder and Scott Gentry, Orlando, Florida. Gregg Cygan/Linda Nouri, Saint Louis, Missouri.

Positions included: cashier, pharmacy technician, pharmacy intern, graduate intern and pharmacist.

TEACHING EXPERIENCE

University of Florida College of Pharmacy, Assistant Professor, July 2002-present

Lecturer: Pharmaceutical Care for Patients with Endocrine, Hematologic and Women’s Health Disorders

PHA 5594 (Working Professional Pharm.D. Program) Summer 2010, Fall 2012

Academic Clerkship Preceptor

Fall 2004-2010, Spring 2011, Spring 2012

Course Coordinator: Pharmacotherapy VI PHA 5788

Spring 2006, 2007, 2008, 2009, 2010, 2011, 2012

Facilitator: Practicum II PHA 5942

Spring 2008

Facilitator: Dosage Forms II PHA 5101

Spring 2006, 2007, 2008

Facilitator: Pharmacotherapy III PHA 5783

Spring 2008, 2009, 2010, 2011, 2012

Lecturer: Pharmacotherapy III PHA 5783

Spring 2009, 2010, 2011, 2012

Facilitator: Professional Communications PHA 5742

Spring 2007

Facilitator: Pharmacotherapy V PHA 5787

Spring 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012

(5)

Facilitator: Pharmacotherapy IV PHA 5784

Fall 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012

Facilitator: Law and Ethics PHA 5239

Fall 2006, 2007, 2008, 2009, 2010, 2011, 2012

Lecturer: Herbal Medicines PHA 5352

Spring 2006, 2007

Lecturer: Pharmacotherapy II PHA 5782

Fall 2003, 2006, 2008, 2009, 2010, 2011, 2012

Campus Coordinator: Pharmaceutical Skills Laboratory I PHA 5108L

Fall 2004, 2005

Facilitator: Pharmaceutical Care for Patients with Respiratory Disorders

PHA 5595 (Working Professional Pharm.D. Program) Summer 2005 (Session 1 only)

Facilitator: Physiological Basis of Disease II PHA 5561C

Spring 2005

Co-Facilitator: Pharmacotherapy II PHA 5782

Fall 2003, 2004

Facilitator: Physiological Basis of Disease I PHA 5560C

Fall 2004

Facilitator: Foundations of Pharmaceutical Care PHA 5629 (Working Professional Pharm.D. Program) Fall 2004

Facilitator: Pharmaceutical Care for Patients with Renal Disorders

PHA 5593 (Working Professional Pharm.D. Program) Fall 2004 (Session 1 only)

(6)

Facilitator: Pharmaceutical Care for Patients with Cardiac Disorders

PHA 5592 Summer 2004

Facilitator: Pharmaceutical Care for Patients with Circulatory Disorders

PHA 5591 Spring 2004

Texas Tech University, Assistant Professor of Pharmacy Practice, July 2000-May 2002 Residency Coordinator/Preceptor

Community Pharmacy Practice Residency July 2000-June 2001

Advanced Community Pharmacy Clerkship PHAR 4479: Preceptor

September 2000-May 2002

Basic Clinical Skills Clerkship PHAR 3275: Preceptor

September 2000-May 2001

Discussion Leader: Case Studies II PHAR 3462

Fall 2001

Lecturer: Herbals, Complementary, and Alternative Medicines PHAR 4228

Spring 2001, Spring 2002

Lecturer: Pharmaceutical Care I PHAR 1301

Spring 2001

Discussion Leader: Pharmacy Practice Journal Club PHAR 3229

Fall 2000

Faculty Attendee: Grand Rounds PHAR 4142

Fall 2000, Spring 2001, Fall 2001, Spring 2002

Saint Louis College of Pharmacy, Clinical Instructor, Pharmacy Practice, July 1999-June 2000 Lecturer: Fluoroquinolones

CP 4700 – Antimicrobial Pharmacotherapy Spring 2000

(7)

Lecturer: Smoking Cessation

PP2100 – Introduction to Pharmaceutical Care and OTC Drugs Spring 2000

Discussion Leader: Weekly Case Discussion Sessions

PP 2100 – Introduction to Pharmaceutical Care and OTC Drugs Spring 2000

Co-preceptor

Doctor of Pharmacy Clinical Clerkships Bachelor of Pharmacy Externship PUBLICATIONS

St. Onge E, Miller S, Clements E. Sitagliptin/metformin (Janumet) as combination therapy in the treatment of type-2 diabetes mellitus. P&T 2012; 37(12): 1-10.

St. Onge E, Suda K, Devaud L, Wilson A, Dutta A, Sacks G, Bricker J. Approaches to management of dilemmas by leaders in academic pharmacy. Currents in Pharmacy Teaching and Learning 2012; 4(2):

78-83.

Williams J, Motycka C, St. Onge E. Evaluating changes in student performance and course evaluations after a course redesign in a pediatric pharmacotherapy course. American Journal of Pharmaceutical Education 2011; 75(10): Article 206.

Miller SA, St. Onge E. Otelixizumab: a novel agent for the prevention of type 1 diabetes mellitus. Expert Opin Biol Ther 2011; 11(11): 1525-32.

St. Onge EL, Miller SA. Role of incretin therapies in the management of type 2 diabetes mellitus: an update. J of Clinical Metab and Diabetes 2011; 2(1): 23-28.

Motycka CA, St. Onge EL, Miller SA. Treatment options for obesity and potential therapies on the horizon. P&T 2011; 36(5): 282-290.

Clayville L, Vogel Anderson K, Miller S, St. Onge E. New options in anticoagulation for VTE and stroke prevention. P&T 2011; 36(2): 86-99.

St. Onge E, Miller S, Vogel Anderson K. Role of incretin therapies in the management of type 2 diabetes mellitus. J of Clinical Metab and Diabetes 2010; 1(2): 1-11.

Whalen K, St. Onge E. Saxagliptin (onglyza) for type 2 diabetes mellitus. American Family Physician 2010; 81(12): 1483-1484.

St. Onge EL, Miller SA. Albiglutide: a new GLP-1 analog for the treatment of type 2 diabetes. Expert Opinion on Biological Therapy 2010; 10(5): 801-806.

(8)

St. Onge EL, Motycka CA, Miller SA. Cardiovascular risk associated with medications used to treat type 2 diabetes mellitus. P&T 2009; 34(7): 368-378.

St. Onge EL, Miller SA, Taylor J. Targeting the incretin effect: a novel approach in the treatment of type 2 diabetes. Journal of Pharmacy Practice 2009; 22(3): 320-332.

Miller SA, St. Onge EL, Accardi JR. Sitagliptin as combination therapy in the treatment of type 2 diabetes mellitus. Diabetes, Metabolic Syndrome, and Obesity: Targets and Therapy 2009; 2: 23-30.

Miller SA, Accardi JR, St. Onge EL. Angiotensin II vaccine: a novel approach in the treatment of hypertension. Expert Opin. Biol. Ther. 2008; 8(11): 1669-1673.

Miller SA, St. Onge EL, Taylor J. DPP-IV inhibitors: a review of sitagliptin, vildagliptin, alogliptin, and saxagliptin. Formulary 2008; 43: 122-134.

St. Onge EL, Miller SA. Pain associated with diabetic peripheral neuropathy: a review of available treatments. P&T 2008; 33(3): 166-176.

Rose RL, St. Onge EL, Tohill J. A review of GERD and its treatment. Drug Topics 2007; 151(1): 46-55.

St. Onge E. Community Pharmacy Practice Case Studies, Chapter __ Insomnia, American Pharmacists Association, Washington, DC, 2009 (Pages)

St. Onge EL, Dea M, Rose RL. Medication errors and strategies to improve patient safety. Drug Topics 2006; 150(9): 36-45.

St. Onge EL, Motycka CA, Rose RL. Type 2 diabetes in children: a growing epidemic. The Journal of Pediatric Pharmacology and Therapeutics 2006; 11(4): 212-222.

Miller SA, St. Onge EL. Sitagliptin: a dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes. Annals of Pharmacotherapy 2006; 40(7): 1336-1343.

St. Onge EL, Rose RL, Alighanbari V. A review of fibromyalgia and its treatment. Drug Topics 2005;

149(22): 38-47.

Rose RL, St. Onge EL, Rose CR. Update on epilepsy. Drug Topics 2005; 149(14): 31-39.

Motycka C, St. Onge E. Current treatments for obesity. Diabetic Microvascular Complications Today 2005; 2(2): 38-45.

Motycka C, St. Onge E. Current treatments for obesity. Drug Topics 2004; 148:61.

St. Onge E, Motycka C. Risks associated with medication use in pregnancy. Drug Topics 2004; 148:

84-93.

Jackson KC, St. Onge EL. Antidepressant pharmacotherapy: considerations for the pain clinician. Pain Practice 2003; 3(2):135-143.

(9)

St. Onge E, Carruthers T, Reddy I. Essentials of diabetes self management and the role of pharmacists.

Drug Store News Continuing Education Quarterly 2002; January-March: 27-32.

St. Onge E. Counseling patients about common skin disorders: a guide for the community pharmacist.

Pharmacy Times 2001; 67(11): 36, 38, 40.

St. Onge E. Wound care for the diabetic patient. Pharmacy Times 2001; 67(10): 44,47.

St. Onge E, Humes S, and Reddy I. Improving diabetic self care: an overview of blood glucose monitoring, skin/foot care, exercise and nutrition. Drug Store News Continuing Education Quarterly 2001; April-June: 25-30.

Peer-reviewed abstracts

Carruthers T and St. Onge E. The impact of pharmacists on elderly patients receiving potentially inappropriate medications in the community pharmacy setting (abstract). JAPhA 2001; 41(2): 293.

St. Onge E and Berry T. Pharmacist interventions in patients with gastrointestinal disorders in the community pharmacy setting: a pilot study (abstract). JAPhA 2000; 40(2): 288.

Professional Newsletters

St. Onge E, Miller S. GLP-1 analogs for the treatment of type 2 diabetes mellitus. FSHP Report 2010;

July: 8.

St. Onge E, Motycka C, Williams J, Normann S, McKenzie M, Ried L, and Riffee W. University of Florida distance education campuses. FSHP Report 2005; 39(2): 15-16.

St. Onge E. Citalopram: A new serotonin selective reuptake inhibitor. PharmaNote 1998; 14(2): 1-4.

Other

St. Onge E, Carruthers T. Diabetes mellitus: are you at risk? Med-Guide 2001; 15th edition: 32.

SERVICE AS A SCIENTIFIC REFEREE

Referee for Cases in Pharmacotherapy text proposal. November 2012.

Manuscript Referee for Pharmacotherapy. August 2009 to present.

Manuscript Referee for P & T. August 2009 to present.

Reviewer for Pharmacist’s Letter/Pharmacy Technician’s Letter. June 2009 to present.

Manuscript Referee for Southern Medical Journal. June 2009 to present.

Manuscript Referee for International Journal of Women’s Health. May 2009 to present.

Manuscript Referee for the American Journal of Pharmaceutical Education. October 2007 to present.

Manuscript Referee for Drugs of Today. January 2006 to present.

(10)

Manuscript Referee for the Journal of the American Pharmacists Association. May 2005 to present.

Manuscript Referee for the Journal of Pediatric Pharmacology and Therapeutics. May 2005 to present.

Abstract Referee for the Annual Meeting and Exposition of the American Pharmaceutical Association held in Philadelphia, PA March 15-19, 2002.

RESEARCH

“Approaches to Management of Ethical Dilemmas by Leaders in Academic Pharmacy.” March 2010 to present. Principal Investigator.

“Student Knowledge of Herbal Medicines Prior to Starting Clinical Rotations.” December 2007 to present. Principal Investigator.

“Survey of Herbals Course Content in Colleges of Pharmacy.” October 2008 to present. Co-investigator.

“Survey of Herbals Clerkship Content at UF College of Pharmacy.” January 2009 to present. Co- investigator.

“Diabetes and Cardiovascular Heart Diseases Screening and Follow-Up of Elderly and Hispanic West Texans by Pharmacists in Urban and Rural Communities.” October 2000-April 2002. Screening Pharmacist.

“Electronic Documentation of Pharmacist Interventions in the Community Pharmacy Setting.” June 2001. Principal Investigator. APhA Incentive Grant for Practitioner Innovation in Pharmaceutical Care.

$1000.

“Pharmacist Interventions in Patients with Gastrointestinal Disorders in the Community Pharmacy Setting.” October 1999. Principal Investigator. APhA Incentive Grant for Practitioner Innovation in Pharmaceutical Care. $1000.

“Developing a Smoking Cessation Program in a Chain Community Pharmacy.” Initiated 1998. Co- investigator: continued existing enrollment and recruited for future enrollment.

PRESENTATIONS

Valvassori P, St. Onge E. How Integrative Models of Care Improve Clinical Outcomes and Quality of Care Delivery. Presented at the National Health Care for the Homeless Conference & Policy Symposium.

June 2011.

St. Onge E, Suda K, Devaud L, Wilson A, Dutta A, Sacks G, Bricker J. Approaches to Management of Ethical Dilemmas by Leaders in Academic Pharmacy. Presented at AACP Meeting. Seattle, WA. June 2010.

(11)

St. Onge EL. A Review of Menopause and its Treatment. CE presented at FPA CE Conference. October 2009.

St. Onge EL. An Overview of Medications Used to Treat Type 2 Diabetes Mellitus. Presented to physicians, physician assistants, nursing staff, pharmacy staff, and pharmacy students at UCF Student Health Care Center. October 2009.

St. Onge EL. Hot Topics in Diabetes. CE presented at CFSHP 2nd Annual Fall CE Seminar. August 2009.

St. Onge EL. Flumist: Intranasal Influenza Vaccine. CE presented to pharmacists enrolled in the Pharmacist’s Immunization Certification Program. University of Florida College of Pharmacy.

September 2008.

St. Onge EL. The Role of the Pharmacist in Providing Immunizations. CE presented to pharmacists enrolled in the Pharmacist’s Immunization Certification Program. University of Florida College of Pharmacy. September 2008.

St. Onge EL, Williams JS, Motycka CA. Teaching through Distance Education: The Experiences of Two Distance Education Programs (Special Session) AACP Meeting. Chicago, IL. July 2008.

St. Onge EL. Teaching OTC Products to Pharmacy Students. (Roundtable) AACP Meeting. San Diego, CA. July 2006.

St. Onge EL. University of Florida College of Pharmacy Distance Campus Sites. Presented to faculty and staff at the Mid Florida Research and Education Center. May 2005.

St. Onge EL. Gastrointestinal Disorders. CE presented to pharmacists enrolled in Community Clinical Skills Workshop. St. Louis College of Pharmacy. March 2000.

St. Onge EL. Reboxetine: A New Antidepressant. Presented to faculty, students, and residents at St.

Louis College of Pharmacy. January 2000.

Poster Presentations at Professional Meetings

Munyer TO, Scolaro K, St. Onge E. “You’re Fired!” Student peer evaluations, bridging competence and professionalism. AACP Annual Meeting. Chicago, IL. July 2008.

Rose RL, St. Onge EL, Motycka CA, Beck DE. Facilitator Training: The essential elements of a facilitator guide. AACP Annual Meeting. Chicago, IL. July 2008.

Motycka CA, St. Onge E, Williams J, Munyer T. Utilizing Classroom Response Systems for Low Stakes Evaluations at Distance Campuses. AACP Annual Meeting. Chicago, IL. July 2008.

Scolaro KL, Ried LD, St. Onge EL, Robinson JD, Taylor JT. Implementation of a Grading Rubric to Improving Grading Consistency in Pharmaceutical Skills Lab. Nonprescription Medicines Academy.

Cincinnati, Ohio. October 2007.

(12)

Inge L, Scolaro K, Rose R, Williams J, St. Onge E, Motycka C, Epstein B, Gums J. Implementation of a Capstone Pharmacy Course in a Distance Education Environment. AACP Annual Meeting, Orlando, Florida. July 2007.

St. Onge E, Rose R, Williams J, Motycka C, Inge L, Scolaro K, Normann S, Beck D. Results of a

Workshop and Lessons Learned: How to Promote Consistency of Instruction Across Multiple Campuses.

AACP Annual Meeting, Cincinnati, Ohio. July 2005.

Inge L, Motycka C, St. Onge E, Williams J. Achieving Consistency in Course Delivery and Student Learning When Using a Blended Learning Model Across Multiple Distance Campuses. AACP Annual Meeting, Cincinnati, Ohio. July 2005.

Motycka CA, Robertson TA, St. Onge EL, Williams JS, Normann SA, Ried LD, McKenzie MW.

Establishing Professionalism in Pharmacy Distance Education. AACP Annual Meeting, Minneapolis, Minnesota. July 2004.

Carruthers TD, St. Onge E. The Impact of Pharmacists on Elderly Patients Receiving Potentially

Inappropriate Medications in the Community Pharmacy Setting. APhA Annual Meeting, San Francisco, California. March 2001.

St. Onge EL, Berry TM. Pharmacist Interventions in Patients with Gastrointestinal Disorders in the Community Pharmacy Setting. APhA Annual Meeting, Washington D.C. March 2000.

Berry TM, St. Onge EL, Middendorf HD. Developing a Smoking Cessation Program in a Chain Community Pharmacy. APhA Annual Meeting, Washington D.C., March 2000.

COMMUNITY SERVICE

May 2011 Central Florida Food Rescue Center – Volunteer

March 2004 Florida Pharmacists’ Health Fair

Participated in health fair for State Legislators to demonstrate the impact pharmacists can have on the health of their patients.

Conducted cholesterol and blood sugar screenings and education.

August 2003, August 2004 Boggy Creek – Pharmacist Volunteer

March 2003 Poison Prevention Coordinator – UFCOP, Orlando Campus Developed and offered poison prevention presentations for elementary age students in several schools in Orlando, Florida.

August 2001 Alliance for Pharmaceutical Care

Participated in the National Convention for State Legislators to demonstrate the impact pharmacists can have on the health of their patients. Conducted demonstrations and education on asthma, H.

pylori, body fat, and osteoporosis.

(13)

March 2001, March 2002 Poison Prevention – Co-Coordinator TTUHSC SOP Developed and offered poison prevention presentations for elementary age students in several schools in Lubbock, Texas.

January 2001 to March 2001 Blood Pressure and Blood Sugar Screenings

Offered blood pressure and blood sugar screenings to the elderly at local senior citizen community centers. Also offered screenings to the indigent and underserved through a church sponsored clinic.

September 2000 Heart and Sole

Speaker for mall walkers club at South Plains Mall. Led discussion on herbal products and diabetes. Also offered blood pressure monitoring to local senior citizens.

COMMITTEE SERVICE

Professionalism Committee

University of Florida College of Pharmacy 9/11-present

Impaired Professionals Committee

University of Florida College of Pharmacy 9/11-present

Self Study Subcommittee on Facilities and Resources

University of Florida College of Pharmacy 04/11-present

Academic Performance Committee

University of Florida College of Pharmacy 8/02-present

Westside Tech Pharmacy Technician Program Advisory Board Member 10/04-8/10 Chair 10/06-5/09

Dean’s Advisory Board Faculty Member 9/02-present

Resident Advisory Committee

Texas Tech University HSC School of Pharmacy 8/00-5/02

Curricular Affairs Subcommittee

Texas Tech University HSC School of Pharmacy 10/00-5/02 PROFESSIONAL AFFILIATIONS

American Society of Health-System Pharmacists Member 1997 to present

Florida Society of Health-System Pharmacists Board of Director’s 8/11-present Board of Director’s Elect 8/10-8/11

(14)

Education Council Co-Chair 2007 to 2009 Education Council Member 2006 to present

Administrative Affairs Council Member 2003 to 2006 Member 2003 to present

Central Florida Society of Health-System Pharmacists Executive Committee 2010 to present

President 4/09 to 12/10 President-Elect 8/07 to 4/09 Member 2003 to present

American College of Clinical Pharmacy

College of Pharmacy Student Liaison 2006 to present 2011 Annual Meeting Program Committee

Member 2000 to 2003, 2006 to present Student CV Reviewer 2007 to present

American Association of Colleges of Pharmacy Member 2002 to present

Kappa Epsilon Pharmaceutical Fraternity, Kappa Chapter Sister 11/95 to present

Phi Lambda Sigma Pharmacy Leadership Society, Iota Chapter Member 1997 to present

LICENSURE

Registered Pharmacist

Missouri License #1999139604 Florida License #PS37305

References

Related documents

Arch Pharyngeal Skeleton in Squalus Squalus Chief Branchiomeric Muscles Tetrapods Cranial Nerve Innervation I Mandibular arch Meckel’s cartilage. Pterygoquadrate

William Heller Campus Dean and Executive Officer University of South Florida

08/16 – Present Associate Dean for Academic Excellence, University of Central Florida, College of Nursing, Academic Health Sciences Center Orlando, FL (Associate Professor, Tenured)

Influenza A mCherry viruses were also able to lethally infect mice, and strikingly, dose- and time-dependent kinetics of viral replication were monitored in whole excised mouse

Clinical Professor of Management, Florida International University, College of Business, Miami, Florida, Jan 2012 to Present.. Awards

College of Pharmacy, Health Science Center, PO Box 100486, University of Florida, Gainesville, Florida 32610-0486 Learning outcomes as measured by exam scores in a

Results: Among the 50 BAL cultures, 25 contained Staphylococcus aureus (methicillin-suscepti- ble S. aureus VAP had a significantly higher mean energy deficit than those S.

The review paper also touches upon key aspects like: (a) Distinguishing engineers from scientists, (b) Their differences in knowledge diffusion, (c) Their communication behaviours,